Calcineurin inhibitor
Tacrolimus
Clear ointment or translucent cream
Typical Strength
0.03%–0.1%
Formulations
0 compounds
Formula
C₄₄H₆₉NO₁₂
Mol. Weight
804.02 g/mol
How It Works
Mechanism of action
Calcineurin inhibitor that blocks T-cell activation and inflammatory cytokine release without the skin-thinning of steroids. Ideal for delicate areas (face, eyelids, folds) in eczema and other steroid-sparing protocols.
What compounding can change
When Tacrolimus is compounded for one patient, your prescriber can choose the concentration, combine it with other ingredients, and pick the base. Commercial products come in fixed strengths and bases.
Safety Considerations
Please note: Compounded medications require a prescription from a licensed prescriber for an individual patient. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness or quality. A compounded medication is not the same as, or a generic version of, any FDA-approved drug. This page is general information, not medical advice. Your prescriber decides whether a treatment is right for you and sets the final ingredients, strength and dosage form.